Management of intracranial melanomas in the era of precision medicine

Authors

Grace J. Young, Harvard Medical School
Wenya Linda Bi, Harvard Medical School
Winona W. Wu, Harvard Medical School
Tanner M. Johanns, Washington University School of Medicine in St. Louis
Gavin P. Dunn, Washington University School of Medicine in St. Louis
Ian F. Dunn, Harvard Medical School

Journal

Oncotarget

Publication Date

2017

Volume

8

Issue

51

Inclusive Pages

89326-89347

Document Type

Open Access Publication

DOI

10.18632/oncotarget.19223

Rights and Permissions

Young, G. J., Bi, W. L., Wu, W. W., Johanns, T. M., Dunn, G. P., & Dunn, I. F. (2017). Management of intracranial melanomas in the era of precision medicine. Oncotarget, 8(51), 89326-89347. doi:10.18632/oncotarget.19223. Copyright: Young et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Recommended Citation

Young, Grace J.; Bi, Wenya Linda; Wu, Winona W.; Johanns, Tanner M.; Dunn, Gavin P.; and Dunn, Ian F., "Management of intracranial melanomas in the era of precision medicine." Oncotarget. 8, 51. 89326-89347. (2017).
https://digitalcommons.wustl.edu/open_access_pubs/6302